Inotiv Overview
- Year Founded
-
1974
- Status
-
Public
- Employees
-
2,046
- Stock Symbol
-
BS50
- Investments
-
16
- Share Price
-
$0.05
- (As of Friday Closing)
Inotiv General Information
Description
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Contact Information
Website
www.inotiv.comCorporate Office
- 2701 Kent Avenue
- West Lafayette, IN 47906
- United States
Corporate Office
- 2701 Kent Avenue
- West Lafayette, IN 47906
- United States
Inotiv Stock Performance
As of 12-Jun-2026, Inotiv’s stock price is $0.05. Its current market cap is $2.79M with 34.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.05 | $2.79M | 34.9M | 645.16 | -$2.52 |
Inotiv Financials Summary
As of 31-Mar-2026, Inotiv has a trailing 12-month revenue of $507M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2025 30-Sep-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 |
|---|---|---|---|---|
| EV | 461,184 | 491,985 | 476,991 | 463,468 |
| Revenue | 507,356 | 513,024 | 490,739 | 572,425 |
| EBITDA | 6,889 | 24,753 | (26,758) | (26,506) |
| Net Income | (86,974) | (68,625) | (108,445) | (105,140) |
| Total Assets | 702,418 | 771,114 | 781,361 | 856,530 |
| Total Debt | 487,766 | 459,288 | 445,767 | 417,641 |
Inotiv Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Inotiv Comparisons
Industry
Financing
Details
Inotiv Competitors (23)
One of Inotiv’s 23 competitors is Charles River Laboratories International, a Formerly PE-Backed company based in Wilmington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| Pharmaron | Formerly VC-backed | Beijing, China | ||||
| Taconic Biosciences | Private Equity-Backed | Rensselaer, NY | ||||
| Solvias | Private Equity-Backed | Kaiseraugst, Switzerland | ||||
| Celerion | Private Equity-Backed | Lincoln, NE |
Inotiv Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Inotiv Patents
Inotiv Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2014504356-A | Apparatus, system and method for collecting body fluid | Active | 11-Oct-2010 | ||
| JP-5885748-B2 | Apparatus, system and method for collecting body fluid | Inactive | 11-Oct-2010 | ||
| ES-2567412-T3 | Devices, systems and methods for collecting body fluids | Active | 11-Oct-2010 | ||
| EP-2628003-A2 | Devices, systems and methods for the collection of body fluids | Active | 11-Oct-2010 | ||
| EP-2628003-A4 | Devices, systems and methods for the collection of body fluids | Active | 11-Oct-2010 | A61B5/150358 |
Inotiv Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Inotiv Investments & Acquisitions (16)
Inotiv’s most recent deal was a Merger/Acquisition with Protypia for . The deal was made on 30-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Protypia | 30-Jul-2022 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Histion | 25-Apr-2022 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Orient BioResource Center | 27-Jan-2022 | Merger/Acquisition | Other Healthcare Services | ||
| Integrated Laboratory Systems | 10-Jan-2022 | Merger/Acquisition | BPO/Outsource Services | ||
| Robinson Services (Rabbit Breeding and Supply Business) | 29-Dec-2021 | Merger/Acquisition | Animal Husbandry |
Inotiv ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
27.47 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Inotiv Exits (1)
Inotiv’s most recent exit was on 01-Jan-2002 from Algorithme Pharma USA. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Algorithme Pharma USA | 01-Jan-2002 | Completed |
|
Inotiv Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pre-Clinical Research Services | Fort Collins, CO | 2005 |
Inotiv FAQs
-
When was Inotiv founded?
Inotiv was founded in 1974.
-
Where is Inotiv headquartered?
Inotiv is headquartered in West Lafayette, IN.
-
What is the size of Inotiv?
Inotiv has 2,046 total employees.
-
What industry is Inotiv in?
Inotiv’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Inotiv a private or public company?
Inotiv is a Public company.
-
What is Inotiv’s stock symbol?
The ticker symbol for Inotiv is BS50.
-
What is the current stock price of Inotiv?
As of 12-Jun-2026 the stock price of Inotiv is $0.05.
-
What is the current market cap of Inotiv?
The current market capitalization of Inotiv is $2.79M.
-
What is Inotiv’s current revenue?
The trailing twelve month revenue for Inotiv is $507M.
-
Who are Inotiv’s competitors?
Charles River Laboratories International, Pharmaron, Taconic Biosciences, Solvias, and Celerion are some of the 23 competitors of Inotiv.
-
What is Inotiv’s annual earnings per share (EPS)?
Inotiv’s EPS for 12 months was -$2.52.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
